Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F38V1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,473
Award facts
- Contract value 100% obligated
- $12,472.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Rytary ER (extended-release levodopa-carbidopa) 36.25 mg-145 mg capsules in a quantity of 100 units, with a ceiling value of $12,472.95. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on December 21, 2025, and scheduled for completion by December 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle extending through December 2026 that provides global pharmaceutical support to military healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Rytary ER is a Parkinson's disease treatment, representing the type of specialized neurological medication that falls within the company's extensive portfolio of federally-procured pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26F38V1?
SPE2DR26F38V1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 21, 2025.
How much is contract SPE2DR26F38V1 worth?
The government has obligated $12,473 on SPE2DR26F38V1.
Is contract SPE2DR26F38V1 an order under another contract?
Yes. SPE2DR26F38V1 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F38V1 competed?
The extent of competition for SPE2DR26F38V1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award